Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Nivolumab × Clear all

Sponsor

Conditions

Melanoma 68 Carcinoma, Non-Small-Cell Lung 63 Carcinoma, Renal Cell 37 Neoplasm Metastasis 28 Neoplasms 25 Squamous Cell Carcinoma of Head and Neck 23 Lung Neoplasms 23 Colorectal Neoplasms 22 Carcinoma, Hepatocellular 18 Small Cell Lung Carcinoma 13 Hodgkin Disease 13 Urinary Bladder Neoplasms 10 Prostatic Neoplasms 10 Multiple Myeloma 10 Carcinoma, Transitional Cell 10 Triple Negative Breast Neoplasms 9 Pancreatic Neoplasms 9 Ovarian Neoplasms 9 Lymphoma 9 Kidney Neoplasms 9 Head and Neck Neoplasms 8 Glioblastoma 8 Stomach Neoplasms 7 Recurrence 7 Leukemia, Myeloid, Acute 7 Glioma 7 Advanced Cancer 7 Myelodysplastic Syndromes 6 Breast Neoplasms 6 Biliary Tract Neoplasms 6

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡